Viewing nowJungkwairozaltan 50mg (Losartan Potassium)
Losartan Potassium 50mg
Tablet · Prescription medication
JW Pharmaceutical Co., Ltd.

MFDS item code 200500661 · Notified 2005.08.10
Treatment of hypertension and nephropathy in patients with type 2 diabetes mellitus accompanied by hypertension
This medication is used for the treatment of hypertension and is especially helpful in protecting kidney function in patients with type 2 diabetes who have hypertension. It effectively controls blood pressure to reduce the risk of cardiovascular complications and slows the progression of kidney disease in diabetic patients. This efficacy significantly assists in the overall health management of patients.
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. Adults with hypertension: The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be divided into 2 oral doses per day or, if necessary, increased to 100 mg once daily. If blood pressure is not controlled with this medicine alone, it may be administered in combination with another antihypertensive medicine (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose is 50 mg of this medicine once daily. Depending on blood pressure, the dose may be increased to 100 mg once daily. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered with insulin or commonly used blood glucose-lowering medicines (e.g., sulfonylureas, glitazones, or glucosidase inhibitors). No adjustment of the initial dose is necessary in older adults aged 75 years or younger. For older adults over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medicine once daily is recommended. For patients who may have reduced effective intravascular volume (e.g., patients receiving diuretic treatment), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). Consider administering a lower dose to patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Children and adolescents aged 6 years or older weighing 20 kg or more but less than 50 kg who can swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. Children and adolescents aged 6 years or older weighing 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Children under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.
This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately if pregnancy is confirmed. Patients with allergies to this medication, severely impaired liver function, women of childbearing potential, and patients with hereditary angioedema should not use it. Elderly patients or those with high potassium levels or impaired liver or kidney function should use this medication cautiously, as there is a risk of a sudden drop in blood pressure. This medication can cause various side effects such as muscle cramps, dizziness, cough, dyspepsia, etc. In severe cases, serious symptoms such as angioedema, hepatitis, or renal failure may occur. Patients with liver dysfunction may need dosage adjustments due to increased blood concentration of this medication, and patients with poor kidney function should also use it cautiously. Taking potassium-supplementing medications or potassium-rich foods can dangerously elevate serum potassium levels, so consultation with a doctor is essential. Caution is also needed when combined with other antihypertensives, diuretics, or non-steroidal anti-inflammatory drugs, as interactions may reduce effectiveness or increase the risk of side effects. Pregnant or breastfeeding women should avoid this medication; if it is absolutely necessary to take, consulting a specialist and stopping breastfeeding is advised. Children, especially those under 6 years old or with very low kidney function, should not use this medication due to undefined safety and efficacy. During the course of taking this medication, regular checks of blood pressure, kidney function, and electrolyte levels should be conducted, and any abnormal symptoms should prompt immediate consultation with healthcare professionals. If blood pressure drops too low or severe side effects occur, discontinue medication and seek immediate treatment. Store this medication out of reach of children and do not transfer it to a different container for safety.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a sealed container. Additionally, it should be kept in a dry place at a temperature between 15 and 30 degrees Celsius to maintain its effectiveness.
White oval film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLosartan Potassium 50mg
Tablet · Prescription medication
JW Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.